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Variation of choroidal thickness and vessel
diameter in patients with posterior non-infectious
uveitis
Millena G Bittencourt1, Saleema Kherani1, Daniel A Ferraz2, Mehreen Ansari1, Humzah Nasir1, Yasir J Sepah3,
Mostafa Hanout3, Diana V Do3 and Quan Dong Nguyen3*

Abstract
Background: Choroidal thickness (CTh) and choroidal vessel diameter (VD) in the Haler’s layer were evaluated as
markers of inflammatory insult in non-infectious uveitis (NIU). Spectral-domain optical coherence tomography
(Spectralis®, Heidelberg Engineering Inc.) scans were acquired from 23 normal subjects (39 eyes – group 1), 7 subjects
with high myopia (14 eyes – group 2), and 19 patients with NIU (23 eyes – group 3). In groups 1 and 2, CTh and VD
were measured at 3 different points of the same horizontal OCT scan passing through the fovea and a mean
calculated. Mean CTh and VD were calculated in 2 other locations, 2 mm superior and inferior from the chosen foveal
horizontal scan. In group 3, three measurements of CTh and VD were obtained within 1 mm of a horizontal scan
passing through a retinal lesion; mean CTh and VD were then computed. A ratio (R) between the VD and the
corresponding CTh was calculated.
Results: Group 1, 2 and 3 mean age was 29.6, 29.1 and 45.9 years, respectively. Sixteen normal subjects, three myopic
subjects and six NIU patients were male.. Group 1 mean CTh did not differ from group 2 (261.6±45.6 vs. 260.2±50.6 µm
µm; p>0.05); mean VD was marginally higher in Group 2 (159.8±32.2 vs. 163.2±33.2 µm; p>0.05). Group 3 demonstrated
thinner CTh (193.6±54.6 µm) than Groups 1 and 2 (p = 0.02 and <0.001). Group 3 mean VD (123.6±37.4 µm) was also
less than that in Groups 1 and 2; the difference was statistically significant only when compared to group 2, p = 0.01. R
did not differ across groups (p-values >0.05), indicating that variations in CTh and VD followed the same trend.
Conclusions: The study reports potential quantitative OCT-derived parameters that may be explored in future trials of
non-infectious uveitis. Thinning of choroid and decrease of vessel diameter are observed in patients with chronic NIU
compared to controls.
Keywords: Choroidal inflammatory disease; Choroidal thickness; Optical coherence tomography; Non-infectious uveitis
and white dot syndrome

Background
Management of non-infectious uveitis (NIU) presents a
unique challenge given the multitude of presentations, associated complications, and a lack of a definitive treatment
thereof. Its pathophysiology and triggers are yet to be fully
understood, consequently making it difficult to identify and
observe biomarkers (anatomic and biochemical) that may
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help in early diagnosis and allow objective assessment of response to therapy.
Careful evaluation is required on part of the care providers to overcome the diagnostic challenge, which is often
made by excluding a list of possible pathologies. Despite
the great advances in diagnostic tests, a definitive diagnosis
still remains elusive in more than 20% of uveitis cases [1].
In addition to infectious and autoimmune serologic assays,
interdisciplinary evaluations, radiologic examination, ultrasonography, and fluorescein and indocyanine angiography,
optical coherence tomography (OCT), a relatively recent
imaging modality, has been used to accurately characterize
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structural damage to the retina and choroid in patients with
NIU. It allows imaging of the retina and choroid with
microscopic resolution, facilitating the differentiation and
follow-up of subtle changes.
Various studies have been conducted to study the morphological changes seen in NIU employing OCT. Qualitative changes in the retinal and choroidal microstructures,
such as choroidal, retinal pigment epithelium (RPE), and
retinal intra-layer hyper reflectivity, have been described in
many of the NIU diagnoses [2-4]. Despite the advances in
the characterization of NIU provided by OCT, OCTderived quantitative outcomes are yet to be evaluated as
predictors of inflammation and functional outcomes.
Since inflammatory diseases of the choriocapillaris and
stromal inflammatory vasculopathy play a role in the
pathogenesis of many of the NIU conditions, changes in
the normal blood circulation in the choroid are expected
[5-9]. We hypothesized that inflammatory mediators
produced in the course of these disorders may yield
changes in choroidal thickness and vessel size and therefore could potentially be used as outcomes in future
clinical trials. The purpose of our study was to quantify
the role of vessel diameter and choroidal thickness as
biomarkers of chronic inflammatory insults in noninfectious uveitis.

Methods
Cross-sectional clinical and imaging data were retrospectively collected from patients in the Retina Division
of the Wilmer Eye Institute, Johns Hopkins Hospital.
Only spectral domain OCT images acquired with Spectralis
HRA+OCT (version 1.5.12.0, Heidelberg Engineering Inc.,
Carlsbad, CA, USA) were used in the study. The standards
of the Helsinki Declaration were followed; written informed
consent was obtained from all participants after the study
approval by the Johns Hopkins Hospital Research Ethics
Committee has been granted.
Demographic information was collected. Spectral domain optical coherence tomography (SD-OCT) images
from participants were divided into three groups: group
1 (normal), group 2 (high myopia), and group 3 (NIU).
Images from normal volunteers with no known ocular
diseases and spherical equivalent refractive error >−6.00
D were assigned to group 1. As some patients in the
NIU cohort had multifocal choroiditis (MFC) and punctate inner choroidopathy (PIC), which are commonly associated with high myopia, a cohort with highly myopic
individuals was included in the study. Highly myopic individuals should have spherical equivalent refractive
error ≤−6.00 D and fundus changes compatible with
myopia and no other pathology associated. Subjects
assigned to group 3 had their diagnoses confirmed after
extensive evaluation by a retina and uveitis specialist
(QDN). Among the ancillary studies employed to reach
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the diagnosis were ophthalmic examinations, infectious
and autoimmune serologic assays, radiologic images, and
interdisciplinary consultation when required, as well as
SD-OCT and fluorescein angiography. Subjects <18 years
old and with any other ocular pathology different from
chronic NIU were excluded from the study.
OCT images with signal-to-noise ratio >15 were included in the study. Images used for analysis followed a
standardized OCT scanning protocol. All images were
acquired using 20° × 15° rectangle with horizontal raster
scans, each comprised at least ≥16 frames per b-scan,
encompassing the macula and optic nerve temporal
border. Manual calipers were used to measure choroidal
thickness (CTh) from the outer hyper-reflective border
of the base of the retinal pigment epithelium (RPE) RPE/BM complex - to the hypo-reflective inner border
of the sclera (Figure 1) [10]. The choroidal layer was further subdivided into Haller's large vessel layer (HLVL) and
Sattler's medium vessel layer (SMVL). Choroidal vessel
diameter (VD) was measured in the HLVL of the choroid,
which is defined as outer choroid large hypo-intense
spaces, representing large vascular luminal spaces [8]. The
imaging measurement algorithm is illustrated in Figure 1.
In normal and myopic subjects, CTh and VD were
measured at three different points of the same OCT
horizontal line and a mean was calculated. Each subject
had the mean CTh and VD calculated for three horizontal lines: one sub-foveal, one 2 mm superior, and one 2
mm inferior from the chosen foveal horizontal scan.
These three locations were used to compute a mean
macular CTh and VD and served as a reference to
analyze the CTh and VD of group 3.
In subjects with NIU, retinochoroidal lesions within
any of the macular quadrants were identified, and the
mean CTh and VD were obtained from three measurements of a given horizontal line passing through each
lesion.
A ratio (R) between the VD measurement and the corresponding CTh measurement was calculated (R = VD/
CTh) and used for comparison among normal, myopic,
and NIU patients.
Statistical analysis

The SPSS (IBM® Inc., Chicago, IL, USA) release 19.0.0
was used for statistical analysis. Demographic characteristics of the patients were summarized using descriptive
statistics and expressed as mean and 95% confidence
intervals. Exploratory data analysis (EDA) was done to
verify the data set characteristics, including covariates,
and to orient the comparison analysis.
A multilevel analysis using a general model with random
intercepts, which took into consideration age, spherical
equivalent refractive error, measurement location, gender,
and ethnicity, was used to compare the CTh, VD, and ratio
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Figure 1 Measurement algorithm. Measurement algorithm in the OCT of a normal subject. A: VD measurement 1, B: CTh measurement 1, C:
VD measurement 2, D: CTh measurement 2, E: VD measurement 3, F: CTh measurement 3

among the three groups. In addition, as the mean CTh, VD,
and R for each horizontal line for the same individual were
analyzed individually, the model was adjusted to assume
that there would be a correlation of retinal scans at two
different levels: eyes and patients. Therefore, a random
intercept for each of these two levels was also included.
Kruskal-Wallis test was used to evaluate potential differences across different diagnoses of NIU. Similarly, MannWhitney test was conducted to compare the CTh, VD, and

ratio between pairs of diagnosis. Mean and confidence
interval were calculated to better visualize the possible
overlapping distributions. A p value of <0.05 was considered statistically significant.

Results
Among the subjects enrolled, 23 had no known ocular
pathology (39 eyes), 7 were highly myopic without any
other retinal pathology (14 eyes), and 19 were patients
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Table 1 Characteristics of study subjects
Age

N
eyes
Group 1

Gender

Ethnicity

Refractive error

Years

SD

Male

Female

C

AF

A

Spherical equivalent

SD

29.6

7.4

18

18

18

4

17

−1.8

1.40

39

Group 2

14

29.1

8.7

8

6

4

2

8

−7.3

2.60

Group 3

23

45.9

14.4

7

16

19

3

1

−4.68

4.00

MFC

8

44.4

8.5

2

6

5

2

1

−5.54

3.50

PIC

4

33.6

3.3

2

2

4

0

0

−8.86

2.30

AZOOR

3

56.0

20.7

0

3

3

0

0

−1.16

0.28

BSCR

6

63.8

9.0

1

5

6

0

0

−1.30

3.00

VKH

1

25

0

1

0

0

1

0

−3.00

0.00

SC

1

38

0

1

0

1

0

0

−1.00

0.00

Group 1: normal subjects; group 2: highly myopic subjects; group 3: subjects with non-infectious uveitis, multifocal choroiditis (MFC), punctate inner choroidopathy
(PIC), acute zonal occult outer retinopathy (AZOOR), birdshot choroidoretinopathy (BSCR), Vogt-Koyanagi-Harada syndrome (VKH), serpiginous choroiditis (SC). C,
Caucasian; AF, African; A, Asian.

were in remission for at least 2 years, ten eyes (43.5%)
were in remission for at least 1 year, six eyes (26.1%)
were in remission for at least 6 months, and three eyes
(13%) were in remission for more than 1 month but less
than 6 months. The mean time of controlled disease was
15.3 (±12.3 SD) months, 60.9% of the eyes were in remission for at least 1 year and 39.1% were in remission
for less than 1 year. Twelve patients were on immunomodulatory therapy (IMT) alone, three patients were on
both IMT and corticosteroids, three patients were taking
less than 10 mg/day of prednisone as monotherapy, and
one was not on any treatment. The 23 eyes were considered as having chronic disease in remission at the time
of the study. Three patients had bilateral and 16 patients
had unilateral ocular involvement. Demographic data
and clinical characteristics of study subjects are summarized in Table 1.
The mean CTh was similar in normal subjects, 261.6 ±
45.6 μm, and myopic subjects, 260.2 ± 50.6 μm. Patients

with various types of NIU (23 eyes). Sixteen (51.6%) of
the normal subjects, three (50%) of the myopic subjects,
and six (35.2%) of the NUI patients were male. Mean
age for normal, myopic, and NIU patients was 29.6, 29.1,
and 45.9 years, respectively. The mean spherical refractive
error in groups 1, 2, and 3 was −1.80 D (SD ±1.4), −7.30 D
(SD ± 2.6), and −4.68 D (SD ±4), respectively. The best
corrected visual acuity in ETDRS letters was 84 ± 3.6 in
group 1, 75 ± 6.4 in group 2, and 69 ± 17 in group 3. In
group 3, eight eyes were from patients diagnosed with
multifocal choroiditis (MFC), four from patients with punctate inner choroidopathy (PIC), six from patients with birdshot chorioretinopathy (BSCR), three from patients with
acute zonal occult outer retinopathy (AZOOR), while one
eye was from a patient with serpiginous chorioretinitis (SC)
and one with Vogt-Koyanagi-Harada (VKH) syndrome.
The NIU mean duration was 7 (±4.6 SD) years. All patients were in disease remission by the time of the study
visit (for the analyses in this study). Four eyes (17.4%)

Table 2 Choroidal thickness, vessel diameter, and ratio characteristics
Choroidal thickness (μm)

Vessel vertical diameter (μm)

Mean

SE

95% CI

Mean

SE

Lower

Upper

Group 1

261.6

4.5

253.1

Group 2

260.2

7.8

Group 3

193.6

8.5

95% CI
Lower

Upper

271.3

159.8

3.2

154.0

244.5

275.5

163.2

5.1

176.9

213.3

123.6

5.8

Ratio
Mean

SE

95% CI
Lower

Upper

166.2

0.61

0.01

0.59

0.65

152.9

174.1

0.62

0.00

0.61

0.64

111.7

135.5

0.61

0.01

0.60

0.67

MFC

187.7

10.4

165.3

210.0

123.1

8.8

104.2

142.0

0.65

0.02

0.6

0.69

PIC

198.4

16.9

159.3

237.5

127.6

11.5

101.0

154.3

0.64

0.02

0.58

0.70

AZOOR

318.8

18.2

240.2

397.3

177.3

13.5

119.1

235.5

0.55

0.04

0.36

0.74

BSCR

160.4

7.1

143.8

177.1

98.2

8.9

77.5

118.9

0.61

0.04

0.51

0.71

VKH

192.5

3.5

148.0

236.9

130.5

26.5

104.0

157.0

0.68

0.15

0.53

0.83

SC

183.2

66.2

117.0

249.5

137.5

45.5

92.0

183.1

0.75

0.02

0.73

0.79

Group 1: normal subjects; group 2: highly myopic subjects; group 3: subjects with non-infectious uveitis, multifocal choroiditis (MFC), punctate inner choroidopathy
(PIC), acute zonal occult outer retinopathy (AZOOR), birdshot choroidoretinopathy (BSCR), Vogt-Koyanagi-Harada syndrome (VKH), serpiginous choroiditis (SC).
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Table 3 Choroidal thickness, vessel diameter, and ratio
characteristics according to location in the fovea
Locations

Normal subjects
N

Mean CTh

Mean VD

Foveal

Mean SD

39 242.8

37.5

Highly myopic subjects
N

Mean

SD

14

248.1

42.0

Supra-foveal 32 271.8

50.4

14

273.1

58.6

Infra-foveal

30 275.3

43.0

14

259.6

50.7

Foveal

39 148.5

28.1

14

152.6

26.9

Supra-foveal 32 173.9

36.8

14

174.8

37.0

Infra-foveal

30 159.5

26.6

14

162.4

33.5

39 0.614

0.086 14

0.618

0.055

Mean ratio Foveal

Supra-foveal 32 0.660

0.242 14

0.644

0.059

Infra-foveal

0.150 14

0.628

0.065

30 0.582

Supra-foveal is defined as 2 mm superiorly to the fovea; infra-foveal is defined
as 2 mm inferiorly to the fovea.

with NIU had thinner mean CTh, 193.6 ± 54.6 μm, as compared to the control groups. The mean VD was found to be
larger in myopic subjects, 163.2 ± 33.2 μm, than in normal
subjects and patients with NIU, 159.8 ± 32.2 μm and 123.6
± 37.4 μm, respectively. Groups 1, 2, and 3 had approximately the same mean ratio, 0.61 ± 0.1, 0.61 ± 0.05, and
0.62 ± 0.01, respectively (p > 0.05) (Table 2).
In normal subjects, the mean CTh has shown to be
greater towards the arcades (mean foveal CTh = 242.8 ±
37.5 μm, mean supra-foveal CTh = 271.8 ± 50.4 μm,
mean infra-foveal CTh = 275.3 ± 43 μm; p < 0.05). Mean
VD was larger superiorly (173.9 ± 36.8 μm) than inferiorly
(159.5 ± 26.6 μm, p > 0.06) and in the fovea (148.5 ±
28.1 μm, p < 0.001); the difference between mean VD in the
fovea and inferiorly was not significant (p = 0.16). The
variation of R across subfield was not statistically significant, p values >0.05. The CTh, VD, and R values have
not shown statistically significant differences between
macular locations in group 2, which may indicate a more
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homogeneous thickness across myopic retinal subfields
(Tables 3 and 4).
The relationship between age, refractive error, gender,
ethnicity, and the study variables were analyzed using
multiple regression analysis. An increase of 1 year has
shown to decrease the CTh by 1.7 μm and the VD by
0.98 μm, p values <0.001. Conversely, the decrease of 1
diopter has shown to increase the CTh by 3.6 μm
(Table 5). Ethnicity was found to have no association
with CTh, VD, and R. In group 3, the association between remission duration and CTh did not show significant strength (r2 = 0.389, p value = 0.96); therefore, this
variable was not included in the model. Likewise, the association between remission duration and vessel diameter
was also not significant (r2 = 0.276, p value = 1.02).
The comparisons among groups were adjusted for
possible differences in age, refractive error, and gender,
and for intra-eye and intra-patient correlation of repeated measurements. Mean CTh was slightly thicker in
group 1 as compared to group 2; the difference, however,
did not differ significantly (p value >0.05). Conversely,
VD was higher in group 2, but not statistically significant
(p = 0.92). Group 3 demonstrated thinner choroid when
compared to groups 1 and 2. The difference was statistically significant with p values <0.05. The VD was also
smaller in this group compared to groups 1 and 2; however, the difference was statistically significant only when
compared to group 2, p = 0.008. The thin CTh of group
3 was not reflected by its group ratio when compared to
groups 1 and 2, p value >0.05 (Table 6).
Among patients with NIU, the mean CTh was found to
be greatest in the AZOOR patients (318.8 μm) followed by
patients with PIC (198.4 μm), VKH (192.5 μm), MFC
(187.7 μm), SC (183.2 μm), and finally BSCR (160.4 μm).
The CTh difference among the various entities was significant (p = 0.04). Mean VD was largest in AZOOR patients

Table 4 Choroidal thickness, vessel diameter, and ratio characteristics according to comparison of locations
in the fovea
Comparison of locations

Normal subjects
Mean
difference

Mean CTh

Mean VD

Foveal × supra-foveal

−27.9

Foveal × infra-foveal
Supra-7foveal × infra-foveal

Highly myopic subjects

95% CI
Lower bound Upper bound

p
Mean
value difference

95% CI
Lower bound Upper bound

p
value

0.006

−25.0

−64.4

14.4

0.206

−10.6

0.003

−11.5

−50.9

27.9

0.557

18.2

0.800

13.5

−25.9

52.9

0.492

−47.5

−8.4

−30.6

−50.6

−2.7

−23.5

Foveal × supra-foveal

−25.1

−39.6

−10.5

0.001

−22.2

−47.6

3.2

0.085

Foveal × infra-foveal

−10.5

−25.3

4.3

0.162

−9.8

−35.1

15.6

0.440

Supra-foveal × infra-foveal

14.6

−0.9

30.1

0.065

12.4

−13.0

37.8

0.328

−0.048

−0.119

0.022

0.176

0.026

−0.026

−0.026

0.253

Foveal × infra-foveal

0.028

−0.044

0.100

0.446

0.016

−0.010

−0.010

0.482

Supra-foveal × infra-foveal

0.076

0.001

0.151

0.057

−0.016

−0.062

0.030

0.482

Mean ratio Foveal × supra-foveal

Supra-foveal is defined as 2 mm superiorly to the fovea; infra-foveal is defined as 2 mm inferiorly to the fovea.
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Table 5 Association of different co-factors with choroidal thickness and vessel diameter
Choroidal thickness (μm)

Vessel vertical diameter (μm)

Effect

p value

Effect

p value

−1.7

<0.001

−0.98

<0.001

Refractive error (⬇ 1 D)

3.6

0.01

0.85

0.390

Gender (M)

18.9

0.07

8.18

0.100

-

0.22

-

0.666

Age (⬆ 1 year)

Ethnicity
D, diopter, M, male.

(177.3 μm), followed by SC (137.5 μm), VKH (130.5 μm),
PIC (127.6 μm), MFC (123.1 μm), and BSCR (98.2 μm);
however, the differences among subgroup were not significant (p = 0.06). R was higher in patients with SC (0.75)
followed by VKH (0.68), MFC (0.65), PIC (0.64), BSCR
(0.61), and then AZOOR (0.55), p = 0.23. The complete description of the CTh, VD, and ratio distribution across patients with different NIU diagnoses is assembled in Table 2.
The CTh and VD intervals are illustrated in Figures 2 and
3. Figure 4 shows the measurements of the VD and CTh of
a patient with BSCR.
Mean differences in CTh and VD were found to be
significant only across AZOOR patients and patients
with MFC, PIC, and BSCR, p values <0.05. The R did
not reflect any differences among subgroups (Table 7).

Discussion
In this cross-sectional study, OCT-derived parameters
were employed to quantitatively evaluate choroidal
changes in a variety of posterior NIUs. The NIU cohort
has shown demographic features in accordance with
those described in the literature for patients with different white dot syndromes (WDSs). The strong female
predilection seen in MFC and PIC, as well as the high
incidence in the third and fourth decades, was confirmed in the study cohort [11]. Similarly, patients with
BSCR, SC, AZOOR, and VKH have revealed characteristics similar to those previously described for these pathologies [12,13].
Variation of CTh and VD were found across different
subfields of the macula. This difference may be explained by physiological and anatomical differences between the retina fields. Light-dark adaptation, exercise,

and blue-flickering stimulus have been shown to induce
choroidal blood flow responses and diversely influence
the CTh and VD across various locations in the posterior pole [14]. It is not unusual to find the thickest portion of the choroid to be underneath the fovea, where
the oxygen requirement is highest, thus requiring high
blood flow [15]. In addition, peripheral, equatorial, and
sub-macular choroid has been shown to differ on the
density of capillaries and inter-capillary space, being
more compacted and thicker in the macula.
Recent studies of macular CTh employing enhanced
depth imaging (EDI)-OCT have made known that subfoveal CTh decreases rapidly in the nasal direction and
less impressively in the temporal direction [10,16]. In
our study, the mean foveal CTh was averaged from three
measurements taken at any point of the foveal horizontal
scan, including the nasal and temporal subfields. Therefore, the overall foveal CTh found in our cohort was thinner than the central foveal CTh reported by other authors
[10,16,17]. However, by using such method, the averaged
foveal CTh could then be used as reference to evaluate
uveitis lesions occurring at any point of the foveal horizontal scan.
The mean CTh measured in normal OCTs was found to
be within the normal range described by Ding et al. In this
study of 420 eyes (mean CTh = 261.93 ± 88.42 μm), the
thickness range was found to be very close to the one reported by Fujiwara and colleagues in a study with 145 eyes
(mean CTh 265.5 ± 82.4 μm) [18,19].
The cohort of patients with NIU showed thinner CTh
and VD than the normal and myopic controls. These
findings support the hypothesis that inflammatory and
ischemic insults to the choroid may occur during

Table 6 Group comparisons
Choroidal thickness (μm)
Group 1 vs. group 2a

Vessel vertical diameter (μm)

Ratio

Difference

p value

Difference

p value

Difference

p value

18.84

0.29

−8.1

0.92

0.029

1.00

a

Group 1 vs. group 3

31.3

0.02

17.96

0.07

0.006

1.00

Group 2 vs. group 3a

50.2

<0.001

26.0

0.01

−0.023

0.31

a

Multivariate model using age and refractive error as covariates (age = 33.16 and Rx = −3.7). Bonferroni test was used to adjust for multiple comparisons.
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Figure 2 Group choroidal thickness and vessel diameter intervals. Choroidal thickness and vessel diameter intervals showing the difference
between group 1 and group3 and between group 2 and group 3.

posterior non-infectious uveitis or may lead to atrophic
changes in the choroidal layers [5,6,20,7]. The discrepancy in the CTh and VD measurements between
groups 2 and 3 shows that co-existing myopia in NIU
patient is not a confounding factor in final NIU
thickness.
Not surprisingly, some variations on the intensity of
CTh and VD atrophy occur across different diagnosis of
NIU. Most likely, it reflects the distinct inflammatory
profile involved in pathophysiology of each entity as well
as the variable vascular involvement.
Recently, Aoyagi and colleagues have reported two
cases of Japanese patients with multiple evanescent
white dot syndrome (MEWDS) who had CTh decrease
from the acute to convalescent phase [21]. Similarly,
Karampelas and collaborators have described loss of
hyporeflectivity in HLVL and thinning of both choroid
and HLVL layer in patients with panuveitis [8]. Furthermore, Keane and colleagues evaluated qualitative and
quantitative choroidal changes in patients with BSCR in
comparison to normal controls using enhanced depth
OCT scans. Their study revealed generalized choroidal

thinning, absence of Sattler's layer, discrete hyperreflective foci, focal depigmentation, and the presence of
supra-choroidal hypo-reflective space [4]. The present
study supports these previous findings; the choroid of
patients with BSCR, SC, and MFC have shown more
profound thinning than those with PIC and VKH, when
compared to normal and highly myopic controls. Even
though it is still controversial whether AZOOR should
be among the so-called white dot syndromes, it is well
known that the majority of the pathologic insults to the
fundus structures occur at the level of RPE and photoreceptor layers, more commonly sparing the choroidal
layers [22,23]. Normal CTh and VD are expected findings for AZOOR, yet it was not seen in our cohort.
Our patients with AZOOR have shown thicker CTh
and VD than normal and highly myopic controls.
There are two conceivable explanations: the small
number of subjects with AZOOR, which may not be
representative of the diseases as a whole, and subclinical acute inflammation leading to the thickening effect
described by Aoyagi and colleagues. Either explanations warrant further evaluation.

Figure 3 Non-infectious uveitis choroidal thickness and vessel diameter intervals. Choroidal thickness and vessel diameter intervals for
different entities of non-infectious uveitis (NIU), showing the differences among AZOOR and other diagnosis.
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Figure 4 Patient with birdshot retinochoroidopathy. Spectral domain OCT of the left eye of a patient with birdshot retinochoroidopathy. The
infrared SLO images (A to C) show the location of the horizontal b-scan. The correspondent b-scans show the vessel diameter and the choroidal
thickness below the different lesions.

The ratio of VD and CTh did not vary significantly
across groups or even within different NIU diagnoses.
Changes in VD followed the overall choroidal thickness
changes. In addition, our cohort was characterized by
patients under effective immunomodulation and therefore was composed of patients with inactive disease. As
described by Aoyagi, vessel dilatation or increased CTh
is more expected in acute inflammatory phase, which

was not the case in the major part of patients enrolled
in our study. The present study shows that the ratio
could not accurately characterize NIU damage.
To our knowledge, our study is the first to evaluate
CTh and VD in various forms of NIU and compared to
controls such as myopic patients and normal subjects.
CTh and VD thinning have shown to be altered in the
remission phase of various NIU and should be further

Table 7 Comparisons between NIU diagnoses
Choroidal thickness (μm)
a

p value = 0.04

Among NIU

Pair-wise comparisonb
MFC vs. PIC

a

Vessel vertical diameter (μm)

Ratio

p value = 0.06

p value = 0.23

Z

p value

Z

p value

Z

p value

−0.48

0.63

−0.28

0.80

−0.05

0.97

MFC vs. AZOOR

−2.66

0.01

−2.23

0.02

−1.67

0.10

MFC vs. BSCR

−1.41

0.16

−1.72

0.08

−0.45

0.67

PIC vs. AZOOR

−2.49

0.01

−1.75

0.07

−1.57

0.11

PIC vs. BSCR

−1.76

0.07

−2.16

0.03

−0.30

0.75

AZOOR vs. BSCR

−2.50

0.01

−2.50

0.01

−1.20

0.22

Kruskal-Wallis test; bMann-Whitney test. VKH and SC were not used for comparison due to the small number of subjects enrolled (1).
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explored as a potential parameter to monitor disease
regression or progression. Our next step is to validate a
semi-automated method to measure CTh and vessel
volume.
There are several study limitations, including the small
number of patients in the subgroup of NIU and the use
of standard SD-OCT images. As the study collected data
retrospectively, the availability of OCTs using EDI was
limited; therefore, it was not incorporated in the study
design. However, this limitation was considered an intrinsic
factor, common to all images, which does not affect the
validity of the results [15,10,24].

Conclusions
The present study reports potential OCT-derived parameters in patients with non-infectious uveitis. We
detected thinning of choroid and decrease of vessel
diameter when compared to matched controls, which
indicates that choroidal thickness and vessel size may
serve as potential (follow-up) parameters to monitor
patients with non-infectious uveitis in future studies.
Further analysis with a larger sample size and semiautomated measurements is indicated to evaluate the
role of choroidal thickness and vessel diameter in the
management of active and inactive uveitic diseases.
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